These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36862550)

  • 1. 4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING.
    Li W; Li Y; Kang J; Jiang H; Gong W; Chen L; Wu C; Liu M; Wu X; Zhao Y; Ren J
    Cell Rep; 2023 Mar; 42(3):112145. PubMed ID: 36862550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Octyl itaconate restricts STING activation by blocking its palmitoylation.
    Su C; Cheng T; Huang J; Zhang T; Yin H
    Cell Rep; 2023 Sep; 42(9):113040. PubMed ID: 37624697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite itaconate in host immunoregulation and defense.
    Yang W; Wang Y; Tao K; Li R
    Cell Mol Biol Lett; 2023 Dec; 28(1):100. PubMed ID: 38042791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1.
    Mills EL; Ryan DG; Prag HA; Dikovskaya D; Menon D; Zaslona Z; Jedrychowski MP; Costa ASH; Higgins M; Hams E; Szpyt J; Runtsch MC; King MS; McGouran JF; Fischer R; Kessler BM; McGettrick AF; Hughes MM; Carroll RG; Booty LM; Knatko EV; Meakin PJ; Ashford MLJ; Modis LK; Brunori G; Sévin DC; Fallon PG; Caldwell ST; Kunji ERS; Chouchani ET; Frezza C; Dinkova-Kostova AT; Hartley RC; Murphy MP; O'Neill LA
    Nature; 2018 Apr; 556(7699):113-117. PubMed ID: 29590092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itaconate is a lysosomal inducer that promotes antibacterial innate immunity.
    Zhang Z; Chen C; Yang F; Zeng YX; Sun P; Liu P; Li X
    Mol Cell; 2022 Aug; 82(15):2844-2857.e10. PubMed ID: 35662396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory response.
    Yang W; Wang Y; Huang Y; Wang T; Li C; Zhang P; Liu W; Yin Y; Li R; Tao K
    Inflammopharmacology; 2024 Feb; 32(1):419-432. PubMed ID: 37470905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation.
    Hooftman A; Angiari S; Hester S; Corcoran SE; Runtsch MC; Ling C; Ruzek MC; Slivka PF; McGettrick AF; Banahan K; Hughes MM; Irvine AD; Fischer R; O'Neill LAJ
    Cell Metab; 2020 Sep; 32(3):468-478.e7. PubMed ID: 32791101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response.
    Sun KA; Li Y; Meliton AY; Woods PS; Kimmig LM; Cetin-Atalay R; Hamanaka RB; Mutlu GM
    Elife; 2020 Apr; 9():. PubMed ID: 32255424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted macrophage phagocytosis by Irg1/itaconate axis improves the prognosis of intracerebral hemorrhagic stroke and peritonitis.
    Luo Z; Sheng Z; Hu L; Shi L; Tian Y; Zhao X; Yang W; Xiao Z; Shen D; Wu W; Lan T; Zhao B; Wang X; Zhuang N; Zhang JN; Wang Y; Lu Y; Wang L; Zhang C; Wang P; An J; Yang F; Li Q
    EBioMedicine; 2024 Mar; 101():104993. PubMed ID: 38324982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis.
    Henderson J; Dayalan Naidu S; Dinkova-Kostova AT; Przyborski S; Stratton R; O Reilly S
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling.
    Sun X; Zhang B; Pan X; Huang H; Xie Z; Ma Y; Hu B; Wang J; Chen Z; Shi P
    FASEB J; 2019 Nov; 33(11):12929-12940. PubMed ID: 31490085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itaconate inhibits SYK through alkylation and suppresses inflammation against hvKP induced intestinal dysbiosis.
    Li Y; Xu Y; Li W; Li J; Wu W; Kang J; Jiang H; Liu P; Liu J; Gong W; Li X; Ni C; Liu M; Chen L; Li S; Wu X; Zhao Y; Ren J
    Cell Mol Life Sci; 2023 Oct; 80(11):337. PubMed ID: 37897551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages.
    Runtsch MC; Angiari S; Hooftman A; Wadhwa R; Zhang Y; Zheng Y; Spina JS; Ruzek MC; Argiriadi MA; McGettrick AF; Mendez RS; Zotta A; Peace CG; Walsh A; Chirillo R; Hams E; Fallon PG; Jayamaran R; Dua K; Brown AC; Kim RY; Horvat JC; Hansbro PM; Wang C; O'Neill LAJ
    Cell Metab; 2022 Mar; 34(3):487-501.e8. PubMed ID: 35235776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IRG1-itaconate axis protects from cholesterol-induced inflammation and atherosclerosis.
    Cyr Y; Bozal FK; Barcia Durán JG; Newman AAC; Amadori L; Smyrnis P; Gourvest M; Das D; Gildea M; Kaur R; Zhang T; Wang KM; Von Itter R; Schlegel PM; Dupuis SD; Sanchez BF; Schmidt AM; Fisher EA; van Solingen C; Giannarelli C; Moore KJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2400675121. PubMed ID: 38564634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects.
    Liao ST; Han C; Xu DQ; Fu XW; Wang JS; Kong LY
    Nat Commun; 2019 Nov; 10(1):5091. PubMed ID: 31704924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IRG1-Itaconate axis: A regulatory hub for immunity and metabolism in macrophages.
    Li Y; Gong W; Li W; Liu P; Liu J; Jiang H; Zheng T; Wu J; Wu X; Zhao Y; Ren J
    Int Rev Immunol; 2023; 42(5):364-378. PubMed ID: 35468044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders.
    Li T; Li JW; Qin YH; Liu R; Xu XN; Li X; Li LM; Feng B; Yang L; Yang CS
    Ann Clin Transl Neurol; 2024 Jul; 11(7):1732-1749. PubMed ID: 38738556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itaconate derivative 4-OI inhibits PRRSV proliferation and associated inflammatory response.
    Pang Y; Wang Y; Li C; Liu J; Duan C; Zhou Y; Fang L; Xiao S
    Virology; 2022 Dec; 577():84-90. PubMed ID: 36323047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Octyl Itaconate Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting Oxidative Stress and Inflammation.
    Li Y; Chen X; Zhang H; Xiao J; Yang C; Chen W; Wei Z; Chen X; Liu J
    Drug Des Devel Ther; 2020; 14():5547-5558. PubMed ID: 33364751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the role of itaconate in macrophage activation and oxidative stress injury in sepsis-associated acute kidney injury.
    Yang L; Zhou P; Li R; Yin Y; Xie G; Shi L; Zhang P; Tao K
    Mol Biol Rep; 2024 Apr; 51(1):533. PubMed ID: 38642169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.